Most Indians experience no or only mild side effects after both doses of Covishield or Covaxin: Survey

Most Indians experience no or only mild side effects after both doses of Covishield or Covaxin: Survey

The survey was conducted among 40,000 people from 381 districts of India of which 62 per cent were men and 38 per cent women.

As India crosses the 60 crore mark for vaccination, the majority of people who took both doses of Covid-19 vaccines experienced no or only mild side effects. A nationwide survey looked at the experiences of people after getting jabbed by either Covishield or Covaxin after India launched the biggest vaccination drive in the world earlier this year.

The survey conducted by Community social media platform LocalCircles found that "70 per cent of Indians who took the first dose of Covishield and 75 per cent who took the second dose experienced no or mild side effects. While 64 per cent of Indians who took the first dose of Covaxin and 78 per cent who took the second dose experienced no or mild side effects."

The mild side effects were experienced within 24-48 houses after taking the vaccine and only 1 per cent of participants had the Covid-19 infection after taking the first dose of Covishield. The participants experienced sore arms, fatigue, and fever as side effects, the survey said.

Thirty per cent of those who took the first dose of Covaxin experienced fever while 1 per cent reported having a more serious condition than fever, and no one reported having a post-vaccine Covid-19 infection, it added. After having the second dose of Covishield, 20 per cent experienced fever, 4 per cent reported getting post-vaccine Covid-19 infection and 1 per cent reported having a more serious condition than fever, the survey said.

Most Indians experience no or only mild side effects after both doses of Covishield or Covaxin: Survey
‘Time is running out’: WHO experts say search for Covid-19 origins ‘stalled’, research at ‘critical juncture’

Stating that the data gathered from the vaccination could be used to reduce vaccine hesitancy, LocalCircles said, "The government must enable a process where a post-vaccination questionnaire is sent over SMS asking those inoculated about what they are experiencing post 1 day, 3 days, 7 and 14 days of taking the dose. Such data can then be utilised. Such information and awareness are likely to help India reduce vaccine hesitancy. As per LocalCircles estimates 16 crore adult citizens are currently vaccine-hesitant."

The survey was conducted among 40,000 people from 381 districts of India of which 62 per cent were men and 38 per cent women. 44 per cent of respondents were from tier 1 cities, 31 per cent from tier 2 and 25 per cent of respondents came from tier 3, 4 and rural districts.

Most Indians experience no or only mild side effects after both doses of Covishield or Covaxin: Survey
India’s COVID-19 vaccination coverage crosses 60-crore mark, says Union Health Minister Mansukh Mandaviya

Over 66 lakh (66,22,337) vaccine doses were administered on Wednesday, according to the 7 pm provisional report and the cumulative number of Covid-19 vaccine doses administered in the country surpassed the 60-crore mark. The countrywide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated in the first phase. The vaccination of frontline workers (FLWs) started on February 2.

Meanwhile, India reported 46,164 new cases in the last 24 hours with an active load going up to 3,33,725. 51.31 crore Covid-19 tests were conducted across the country.

Related Stories

No stories found.
Indians In Gulf
www.indiansingulf.in